Singapore markets closed

Repare Therapeutics Inc. (RPTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.84+0.39 (+4.13%)
At close: 04:00PM EDT
10.04 +0.20 (+2.03%)
After hours: 07:43PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
120,509
131,830
7,600
135
0
Operating expenses
Research development
117,147
119,066
90,047
40,091
20,995
Selling general and administrative
32,260
32,560
26,213
14,346
5,382
Total operating expenses
149,407
151,626
116,260
54,437
26,377
Operating income or loss
-28,898
-19,796
-108,660
-54,302
-26,377
Total other income/expenses net
122
265
-185
-680
-644
Income before tax
-25,972
-13,900
-108,586
-54,742
-27,021
Income tax expense
-293
15,147
-1,678
-1,325
195
Income from continuing operations
-25,679
-29,047
-106,908
-53,417
-27,216
Net income
-25,679
-29,047
-106,908
-53,417
-27,216
Net income available to common shareholders
-25,679
-29,047
-106,908
-53,417
-25,866
Basic EPS
-
-
-2.83
-2.66
-1.64
Diluted EPS
-
-
-2.83
-2.66
-1.64
Basic average shares
-
-
37,818
20,046
15,791
Diluted average shares
-
-
37,818
20,046
15,791
EBITDA
-
-17,818
-107,189
-53,405
-25,772